SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CONTOLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.791
AS - Asia 8.453
EU - Europa 5.015
SA - Sud America 1.311
Continente sconosciuto - Info sul continente non disponibili 442
AF - Africa 186
OC - Oceania 32
AN - Antartide 1
Totale 31.231
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.365
SG - Singapore 3.292
CN - Cina 1.833
IT - Italia 1.536
BR - Brasile 1.011
VN - Vietnam 919
DE - Germania 791
HK - Hong Kong 694
UA - Ucraina 507
FI - Finlandia 471
BD - Bangladesh 468
GB - Regno Unito 400
TR - Turchia 345
FR - Francia 301
SE - Svezia 240
JP - Giappone 221
PL - Polonia 205
RU - Federazione Russa 197
CA - Canada 190
ID - Indonesia 179
IN - India 164
MX - Messico 149
AR - Argentina 121
NL - Olanda 105
ZA - Sudafrica 67
IQ - Iraq 55
PK - Pakistan 53
ES - Italia 50
EC - Ecuador 39
CO - Colombia 38
UZ - Uzbekistan 36
AT - Austria 32
BE - Belgio 32
LT - Lituania 32
PY - Paraguay 29
PH - Filippine 26
AU - Australia 25
MA - Marocco 24
CZ - Repubblica Ceca 22
VE - Venezuela 22
KR - Corea 21
MY - Malesia 21
JM - Giamaica 20
TN - Tunisia 17
CL - Cile 16
KE - Kenya 16
PE - Perù 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
EG - Egitto 13
UY - Uruguay 13
IE - Irlanda 12
JO - Giordania 12
CR - Costa Rica 10
AZ - Azerbaigian 9
CH - Svizzera 9
GT - Guatemala 9
TW - Taiwan 9
AL - Albania 8
NI - Nicaragua 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
HN - Honduras 7
HR - Croazia 7
HU - Ungheria 7
BB - Barbados 6
ET - Etiopia 6
GE - Georgia 6
KH - Cambogia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
LB - Libano 5
LK - Sri Lanka 5
MK - Macedonia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
EU - Europa 4
KG - Kirghizistan 4
MD - Moldavia 4
NG - Nigeria 4
BG - Bulgaria 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GY - Guiana 3
MU - Mauritius 3
SI - Slovenia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
Totale 30.748
Salva come PNG Salva come JPEG
Città #
Singapore 2.017
Ashburn 1.922
Fairfield 1.248
San Jose 1.077
Woodbridge 1.044
Houston 976
Santa Clara 699
Hong Kong 682
Beijing 568
Jacksonville 561
Chandler 537
Ann Arbor 508
Seattle 508
Council Bluffs 507
Wilmington 494
Cambridge 429
Munich 378
Los Angeles 332
New York 326
Ho Chi Minh City 310
Helsinki 280
Dallas 247
Hanoi 211
Milan 211
Tokyo 208
Warsaw 189
Ferrara 188
Izmir 187
Nanjing 179
Princeton 170
Lauterbourg 164
Jakarta 134
Chicago 108
San Diego 107
São Paulo 100
Rome 97
Boardman 91
Shanghai 89
Mexico City 87
Toronto 85
Orem 72
London 71
Atlanta 66
Buffalo 65
Addison 64
Turku 57
Dearborn 55
Frankfurt am Main 52
Nanchang 50
Da Nang 49
Shenyang 49
San Francisco 47
Tianjin 47
Bologna 46
Brooklyn 44
Hefei 44
Washington 43
The Dalles 41
Chennai 40
Phoenix 40
Denver 39
Montreal 39
Mountain View 36
Boston 32
Changsha 32
Moscow 32
Tashkent 32
Rio de Janeiro 31
Hebei 30
Nuremberg 30
Brussels 29
Haiphong 29
Jiaxing 29
Amsterdam 28
Redwood City 28
Johannesburg 27
Salt Lake City 27
Falls Church 26
Guangzhou 26
Naples 25
Columbus 24
Dhaka 24
Manchester 24
Stockholm 23
Florence 22
Jinan 22
Lappeenranta 22
Norwalk 22
Baghdad 21
Turin 20
Ankara 19
Bremen 19
Miami 19
Falkenstein 18
Istanbul 18
Mumbai 18
Orange 18
Palermo 18
Buenos Aires 17
New Delhi 17
Totale 20.309
Salva come PNG Salva come JPEG
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 534
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 445
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 366
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 360
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 349
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 331
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 318
Targeting Th2 cells in asthmatic airways 306
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 289
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 280
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 277
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 268
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 266
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 265
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 264
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 258
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 255
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 249
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 243
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 243
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 237
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 234
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 226
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 225
A serum proteome signature to predict mortality in severe COVID-19 patients 222
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 220
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 220
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 219
Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study 218
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 216
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 214
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 214
Cellule staminali e patologia polmonare dell’adulto 212
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 210
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 210
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 209
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 206
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 205
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 202
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 202
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 200
Rhinovirus vaccination: the case against 196
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 194
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 194
Models of infection and exacerbations in COPD. 192
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 190
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 189
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 188
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 187
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 186
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 186
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 184
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 183
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 182
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 182
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 181
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 179
Asthma: A Chronic Infectious Disease? 179
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 179
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 178
Disease awareness in patients with COPD: measurement and extent 175
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 175
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 174
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 173
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 172
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School Children 171
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 169
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 169
Interactions of airway pathogens and inflammatory processes 169
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 168
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 167
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 166
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 166
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 166
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 165
Pathophysiology of viral-induced exacerbations of COPD 164
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 164
The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study 163
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 163
When asthma diagnosis becomes a challenge 162
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 159
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 159
Interactions of airway pathogens and inflammatory processes 159
Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias 159
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 158
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 156
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 156
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 156
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 154
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 153
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 153
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 152
Deficient immune response to viral infections in children predicts later Asthma persistence 152
Small airway disease in asthma: pathophysiological and diagnostic considerations 151
Diffuse panbronchiolitis as parathymic syndrome in a Caucasian man previously treated for thymoma 150
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 150
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 149
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 148
Mechanisms of respiratory virus-induced asthma exacerbations 147
Totale 20.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.698
Totale 152.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.455 0 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.690 100 107 363 166 530 446 208 290 833 523 596 528
2025/202612.924 1.084 493 1.032 1.460 1.910 791 1.547 748 1.214 1.266 874 505
2026/20271.194 428 766 0 0 0 0 0 0 0 0 0 0
Totale 31.231